LuCE REPORT ON LUNG CANCER Challenges in lung cancer in Europe
LuCE-Report-final
LuCE-Report-final
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Incidence of <strong>lung</strong> <strong>cancer</strong> <strong>in</strong> the EU countries*,<br />
by age-standardized rate (world) <strong>in</strong> both<br />
sexes<br />
There are important differences <strong>in</strong> the lifetime risk of develop<strong>in</strong>g<br />
this disease across different countries. For <strong>in</strong>stance, around 3 out<br />
of 100 men <strong>in</strong> Sweden, Cyprus, F<strong>in</strong>land and Malta will develop <strong>lung</strong><br />
<strong>cancer</strong> dur<strong>in</strong>g their lives, while this number goes up to 9 <strong>in</strong> every<br />
100 <strong>in</strong> Hungary, and to 7 <strong>in</strong> every 100 men <strong>in</strong> Poland, Belgium,<br />
Croatia, Romania, Lithuania and Latvia3. The <strong>in</strong>cidence rate <strong>in</strong> 23<br />
<strong>Europe</strong>an countries is higher than the worldwide average (23.1<br />
per 100,000). Hungary has the highest <strong>in</strong>cidence of <strong>lung</strong> <strong>cancer</strong>,<br />
with an age-standardized rate of 51.6 per 100,000. This is more<br />
than 20 po<strong>in</strong>ts higher than the EU average, and 28 higher than<br />
the worldwide rate. In the EU, Hungary is followed by Denmark,<br />
Poland, the Netherlands and Belgium. These countries also<br />
present high rates of <strong>in</strong>cidence (over 36.0 per 100,000).<br />
Consider<strong>in</strong>g absolute numbers, <strong>lung</strong> <strong>cancer</strong> is the highest <strong>cancer</strong><br />
<strong>in</strong>cidence <strong>in</strong> four <strong>Europe</strong>an countries (Greece, Hungary, Poland<br />
and Romania) and the second highest <strong>in</strong> Bulgaria, Croatia, Latvia<br />
and Lithuania<br />
*EU-28 (+ Israel + Norway + Switzerland: <strong>in</strong>cluded because they have<br />
patient member organisations of Lung Cancer <strong>Europe</strong>)<br />
Source: GLOBOCAN 2012<br />
16 17